High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists.
about
A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAARTDetermination of viral tropism by genotyping and phenotyping assays in Brazilian HIV-1-infected patients.Appraising the performance of genotyping tools in the prediction of coreceptor tropism in HIV-1 subtype C virusesA genotypic test for HIV-1 tropism combining Sanger sequencing with ultradeep sequencing predicts virologic response in treatment-experienced patientsGenotypic prediction of tropism of highly diverse HIV-1 strains from CameroonHIV-1 tropism: a comparison between RNA and proviral DNA in routine clinical samples from Chilean patientsHigh prevalence of CXCR4 usage among treatment-naive CRF01_AE and CRF51_01B-infected HIV-1 subjects in Singapore.HIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01_AE and CRF02_AG [corrected].Genotypic prediction of HIV-1 subtype D tropismImpact of baseline HIV-1 tropism on viral response and CD4 cell count gains in HIV-infected patients receiving first-line antiretroviral therapy.Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy.Concordance of HIV type 1 tropism phenotype to predictions using web-based analysis of V3 sequences: composite algorithms may be needed to properly assess viral tropismGenotypic prediction of HIV-1 CRF01-AE tropism.Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study groupDetermination of HIV tropism and its use in the clinical practice.Effect of HIV-1 subtype and tropism on treatment with chemokine coreceptor entry inhibitors; overview of viral entry inhibition.High concordance between the position-specific scoring matrix and geno2pheno algorithms for genotypic interpretation of HIV-1 tropism: V3 length as the major cause of disagreementThe Pace of Co-receptor Tropism Switch in HIV-1 Infected Individuals after Recent Infection.Genotypic tropism of antiretroviral-treated patients with drug resistant HIV-1.Determination of the high prevalence of Dual/Mixed- or X4-tropism among HIV type 1 CRF01_AE in Hong Kong by genotyping and phenotyping methods.Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patients.Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study.Factors influencing the sensitivity and specificity of conventional sequencing in human immunodeficiency virus type 1 tropism testing.Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure.Evolution of HIV-1 quasispecies and coreceptor use in cell reservoirs of patients on suppressive antiretroviral therapy.Algorithm-based prediction of HIV-1 subtype D coreceptor useDiscordance in HIV-1 co-receptor use prediction by different genotypic algorithms and phenotype assay: intermediate profile in relation to concordant predictions.
P2860
Q28542548-B2D4B25B-D025-45F0-9C2D-0C0D91016005Q34040770-024EF0C2-2EC0-4160-85A0-0C274E7660BCQ34400487-41D1DC3E-E9AE-4668-9CEF-2AC07CABCA5DQ34431102-61057189-9578-441B-A068-4ACB97B2B154Q34473354-0EE81D91-8CA7-4A42-90F5-CDE565C15E79Q34508492-885088D5-325B-4C30-B930-72210FAE7EE9Q34591699-79E82986-089A-41D4-94FE-E74CF85868FEQ34716813-DF7802BE-27AB-4B4C-80F1-BD6A4D47216CQ35137552-90DA5F03-CED4-4BB6-83DE-7D4F3417CABFQ35838609-4F7B3167-0BD1-4DDE-9BAF-B217B94A0DC5Q35953203-66DB7D33-C3E7-494B-B1F1-11F59E6BE9B8Q36050112-89C836E3-2A70-4EC5-A076-9F86796F2B78Q36559004-5712E435-E584-4F6C-8BD0-8B9358DE7582Q37530942-ABA9570A-D074-4E94-B6E9-9296808F5889Q38160078-3EA9968B-0148-4357-A7D3-75091E284241Q38196457-1552FED0-CE2F-4B5A-A000-5F879A2BAAA4Q38285227-1AF65010-7021-47FF-A8F7-80643D0CA993Q38703857-2399F5EB-15C9-4B2F-9C58-E10EAF350BECQ39338065-272A3F1A-0CD9-4C93-A550-0B49FF102A5FQ39424156-2DDC6FC7-9D72-4175-B029-30D943C1F741Q39730219-0E246EB7-DF01-4319-B272-593FF8A43085Q40390568-7610C779-5A44-4390-AD99-F909584305FAQ41967834-6D0B30D2-C6AB-4B18-BB45-3B6A947C42D8Q42206476-2644C1CA-5BD0-4EC0-9072-C5C1D836B2C6Q42217903-A613B117-8FB5-4A91-83F3-903EF242E97FQ42287937-4B6E6570-6E05-4A7E-8FD5-26A97ABE0B3EQ51450830-2A75FAA1-EC95-4AEC-A26B-6FA7AAA421F2
P2860
High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
High sensitivity of specific g ...... treated with CCR5 antagonists.
@en
High sensitivity of specific g ...... treated with CCR5 antagonists.
@nl
type
label
High sensitivity of specific g ...... treated with CCR5 antagonists.
@en
High sensitivity of specific g ...... treated with CCR5 antagonists.
@nl
prefLabel
High sensitivity of specific g ...... treated with CCR5 antagonists.
@en
High sensitivity of specific g ...... treated with CCR5 antagonists.
@nl
P2093
P2860
P356
P1476
High sensitivity of specific g ...... treated with CCR5 antagonists.
@en
P2093
Carmen de Mendoza
Carolina Garrido
Eduardo Seclén
Juan González-Lahoz
María del Mar González
P2860
P304
P356
10.1093/JAC/DKQ137
P407
P577
2010-04-28T00:00:00Z